• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化脓性链球菌咽炎会引发对关键疫苗抗原的多种抗体反应,这些反应受既往感染印记的影响。

Streptococcus pyogenes pharyngitis elicits diverse antibody responses to key vaccine antigens influenced by the imprint of past infections.

作者信息

Osowicki Joshua, Frost Hannah R, Azzopardi Kristy I, Whitcombe Alana L, McGregor Reuben, Carlton Lauren H, Baker Ciara, Fabri Loraine, Pandey Manisha, Good Michael F, Carapetis Jonathan R, Walker Mark J, Smeesters Pierre R, Licciardi Paul V, Moreland Nicole J, Hill Danika L, Steer Andrew C

机构信息

Tropical Diseases Research Group, Murdoch Children's Research Institute, Melbourne, VIC, Australia.

Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.

出版信息

Nat Commun. 2024 Dec 3;15(1):10506. doi: 10.1038/s41467-024-54665-5.

DOI:10.1038/s41467-024-54665-5
PMID:39627204
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11614873/
Abstract

Knowledge gaps regarding human immunity to Streptococcus pyogenes have impeded vaccine development. To address these gaps and evaluate vaccine candidates, we established a human challenge model of S. pyogenes pharyngitis. Here, we analyse antibody responses in serum and saliva against 19 antigens to identify characteristics distinguishing 19 participants who developed pharyngitis and 6 who did not. We show that pharyngitis elicits serum IgG responses to key vaccine antigens and a muted mucosal IgA response, whereas IgG responses are minimal and IgA responses more pronounced in participants without pharyngitis. Serum IgG responses to pharyngitis in adult participants resemble those in children and are inversely correlated with the magnitude of pre-existing responses. While a straightforward correlate of protection is not evident, baseline antibody signatures distinguish clinical and immunological outcomes following experimental challenge. This highlights the influence of a complex humoral imprint from previous exposure, relevant for interpreting immunogenicity in forthcoming vaccine trials.

摘要

关于人类对化脓性链球菌免疫的知识空白阻碍了疫苗的研发。为了填补这些空白并评估候选疫苗,我们建立了化脓性链球菌咽炎的人体激发模型。在此,我们分析血清和唾液中针对19种抗原的抗体反应,以确定区分19名患咽炎参与者和6名未患咽炎参与者的特征。我们发现,咽炎会引发血清IgG对关键疫苗抗原的反应以及微弱的黏膜IgA反应,而在未患咽炎的参与者中,IgG反应极小,IgA反应更为明显。成年参与者对咽炎的血清IgG反应与儿童相似,且与既往反应的强度呈负相关。虽然保护的直接关联尚不明显,但基线抗体特征可区分实验激发后的临床和免疫结果。这凸显了既往接触产生的复杂体液印记的影响,这对于解释即将进行的疫苗试验中的免疫原性具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2ae/11614873/e298a343d4cf/41467_2024_54665_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2ae/11614873/a8c212933955/41467_2024_54665_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2ae/11614873/749460ae6ca9/41467_2024_54665_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2ae/11614873/ae25fab2c7da/41467_2024_54665_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2ae/11614873/b502c0474760/41467_2024_54665_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2ae/11614873/4da80247f73a/41467_2024_54665_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2ae/11614873/b7e58741582a/41467_2024_54665_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2ae/11614873/e298a343d4cf/41467_2024_54665_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2ae/11614873/a8c212933955/41467_2024_54665_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2ae/11614873/749460ae6ca9/41467_2024_54665_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2ae/11614873/ae25fab2c7da/41467_2024_54665_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2ae/11614873/b502c0474760/41467_2024_54665_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2ae/11614873/4da80247f73a/41467_2024_54665_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2ae/11614873/b7e58741582a/41467_2024_54665_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2ae/11614873/e298a343d4cf/41467_2024_54665_Fig7_HTML.jpg

相似文献

1
Streptococcus pyogenes pharyngitis elicits diverse antibody responses to key vaccine antigens influenced by the imprint of past infections.化脓性链球菌咽炎会引发对关键疫苗抗原的多种抗体反应,这些反应受既往感染印记的影响。
Nat Commun. 2024 Dec 3;15(1):10506. doi: 10.1038/s41467-024-54665-5.
2
Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes.由活的重组乳酸乳球菌制成的黏膜疫苗可保护小鼠免受化脓性链球菌的咽部感染。
Infect Immun. 2004 Jun;72(6):3444-50. doi: 10.1128/IAI.72.6.3444-3450.2004.
3
Protective immunity induced by an intranasal multivalent vaccine comprising 10 Lactococcus lactis strains expressing highly prevalent M-protein antigens derived from Group A Streptococcus.由包含10株表达源自A组链球菌的高度流行M蛋白抗原的乳酸乳球菌菌株的鼻内多价疫苗诱导的保护性免疫。
Microbiol Immunol. 2018 Jun;62(6):395-404. doi: 10.1111/1348-0421.12595. Epub 2018 Jun 11.
4
Vaccine Approaches To Protect against Group A Streptococcal Pharyngitis.疫苗接种预防 A 组链球菌咽炎的方法。
Microbiol Spectr. 2019 May;7(3). doi: 10.1128/microbiolspec.GPP3-0010-2018.
5
Immune response against M protein-conserved region peptides from prevalent group A Streptococcus in a North Indian population.印度北部人群中针对流行的A组链球菌M蛋白保守区肽段的免疫反应
J Microbiol Immunol Infect. 2016 Jun;49(3):352-8. doi: 10.1016/j.jmii.2014.05.008. Epub 2014 Jul 30.
6
Vaccination with Streptococcus pyogenes nuclease A stimulates a high antibody response but no protective immunity in a mouse model of infection.用化脓性链球菌核酸酶A进行疫苗接种在小鼠感染模型中可刺激产生高抗体反应,但无保护性免疫。
Med Microbiol Immunol. 2015 Apr;204(2):185-91. doi: 10.1007/s00430-014-0353-2. Epub 2014 Aug 15.
7
The human antibody response to streptococcal C5a peptidase.人类对链球菌C5a肽酶的抗体反应。
J Infect Dis. 1991 Jan;163(1):109-16. doi: 10.1093/infdis/163.1.109.
8
An Experimental Group A Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model.一种实验组 A 疫苗,可减少非人类灵长类动物模型中的咽炎和扁桃体炎。
mBio. 2019 Apr 30;10(2):e00693-19. doi: 10.1128/mBio.00693-19.
9
Oral immunization of mice with engineered Lactobacillus gasseri NM713 strain expressing Streptococcus pyogenes M6 antigen.用表达化脓性链球菌M6抗原的工程化加氏乳杆菌NM713菌株对小鼠进行口服免疫。
Microbiol Immunol. 2016 Aug;60(8):527-32. doi: 10.1111/1348-0421.12397.
10
Salivary and serum antibody response to Streptococcus mutans antigens in humans.人类对变形链球菌抗原的唾液和血清抗体反应。
Oral Microbiol Immunol. 2000 Apr;15(2):131-8. doi: 10.1034/j.1399-302x.2000.150210.x.

引用本文的文献

1
Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden setting.高负担环境下儿童早期血清学特征及对化脓性链球菌天然保护性体液免疫的发展
Nat Med. 2025 Aug 8. doi: 10.1038/s41591-025-03868-4.
2
New evidence supports a greater focus on streptococcal skin infections to prevent rheumatic fever.新证据支持更关注链球菌性皮肤感染以预防风湿热。
Med J Aust. 2025 Aug 4;223(3):114-116. doi: 10.5694/mja2.52708. Epub 2025 Jun 18.

本文引用的文献

1
Development and characterization of a hemolysis inhibition assay to determine functionality of anti-Streptolysin O antibodies in human sera.开发并鉴定一种溶血抑制检测法,以测定人血清中抗链球菌溶血素 O 抗体的功能。
J Immunol Methods. 2024 Mar;526:113618. doi: 10.1016/j.jim.2024.113618. Epub 2024 Jan 16.
2
Global Streptococcus pyogenes strain diversity, disease associations, and implications for vaccine development: a systematic review.全球化脓性链球菌菌株多样性、疾病关联及其对疫苗开发的影响:系统评价。
Lancet Microbe. 2024 Feb;5(2):e181-e193. doi: 10.1016/S2666-5247(23)00318-X. Epub 2023 Dec 6.
3
Naturally acquired functional antibody responses to group A differ between major strain types.
自然获得的针对 A 群的功能性抗体应答在主要菌株类型之间存在差异。
mSphere. 2023 Oct 24;8(5):e0017923. doi: 10.1128/msphere.00179-23. Epub 2023 Sep 20.
4
Strategic and scientific contributions of human challenge trials for vaccine development: facts versus fantasy.人类挑战试验在疫苗研发中的战略和科学贡献:事实与幻想。
Lancet Infect Dis. 2023 Dec;23(12):e533-e546. doi: 10.1016/S1473-3099(23)00294-3. Epub 2023 Aug 10.
5
Molecular correlates of vaccine-induced protection against typhoid fever.疫苗预防伤寒的分子相关性。
J Clin Invest. 2023 Aug 15;133(16):e169676. doi: 10.1172/JCI169676.
6
Streptococcus pyogenes Colonization in Children Aged 24-59 Months in the Gambia: Impact of Live Attenuated Influenza Vaccine and Associated Serological Responses.冈比亚 24-59 月龄儿童中化脓性链球菌定植:减毒活流感疫苗的影响及其相关血清学反应。
J Infect Dis. 2023 Oct 3;228(7):957-965. doi: 10.1093/infdis/jiad153.
7
Safety of Streptococcus pyogenes Vaccines: Anticipating and Overcoming Challenges for Clinical Trials and Post-Marketing Monitoring.A 族链球菌疫苗的安全性:临床试验和上市后监测中挑战的预测和克服。
Clin Infect Dis. 2023 Sep 18;77(6):917-924. doi: 10.1093/cid/ciad311.
8
Serum Immune Responses to Group A Streptococcal Antigens following Pharyngeal Acquisitions among Children in Cape Town, South Africa.南非开普敦儿童咽部获得性 A 组链球菌抗原的血清免疫反应。
mSphere. 2023 Jun 22;8(3):e0011323. doi: 10.1128/msphere.00113-23. Epub 2023 May 8.
9
Immunological imprinting: Understanding COVID-19.免疫印记:了解 COVID-19。
Immunity. 2023 May 9;56(5):909-913. doi: 10.1016/j.immuni.2023.04.012. Epub 2023 Apr 19.
10
Pathogenesis, epidemiology and control of Group A Streptococcus infection.A 组链球菌感染的发病机制、流行病学和控制。
Nat Rev Microbiol. 2023 Jul;21(7):431-447. doi: 10.1038/s41579-023-00865-7. Epub 2023 Mar 9.